Dr. Drappatz is a leading expert in brain cancer treatment and research. As a board- certified neurologist specializing in the field of neuro-oncology, his primary areas of research involve the development of novel agents for the treatment of gioblastoma, central nervous system lymphoma, and other primary and metastatic brain tumors. He has served as the principal investigator of numerous clinical trials to identify effective therapies for patients with brain tumors and other neurological ailments associated with cancer.
Dr. Drappatz received his medical degree from the Johannes Gutenberg University School of Medicine. He completed residency training in neurology at the Partners Neurology Residency Program at Massachusetts General Hospital and Brigham and Women’s Hospital, Harvard Medical School, and completed his fellowship training in neuro-oncology at Dana-Farber Cancer Institute.
He is a member of several professional organizations, including the American Association for Cancer Research, American Society of Clinical Oncology, the Society for Neuro-Oncology, and the “Alliance for Clinical Trials in Oncology” brain tumor committee.